Mouse morulae, blastocysts, and embryonic and extraembryonic tissue layers were examined for benzo[aJpyrene metabolism by cytochrome P-450, using the sister chromatid exchange assay. Benzo[alpyrene exposure in vitro increased sister chromatid exchanges in blastocysts of all genetically responsive mice examined [BALB/cDub, C3H/AnfCum, and outbred Dub:(ICR) strains] but not blastocysts of the nonresponsive AKR/J strain. Benzo[alpyrene treatment of responsive 71/2-and 81/2-day (postimplantation-stage) embryos, either intact or as separate tissue layers, increased sister chromatid exchanges in tissues of both embryonic and extraembryonic lineages-i.e., in the embryo proper, in isolated embryonic ectoderm, and in yolk sac, chorion, extraembryonic ectoderm, and extraembryonic endoderm layers. These results indicate that cytochrome P-450 is active in most or all tissues of the early mammalian embryo. It could metabolize xenobiotic molecules reaching the conceptus near the onset of morphogenesis and organogenesis, or it could have another as yet undefined role in normal development.
indicating the expression of cytochrome P-450 activity at 7'/2 to 81/2 days of gestation (8) . Preimplantation embryos at the blastocyst stage can metabolize benzo[a]pyrene, as assessed by analysis of embryo culture medium using high-pressure liquid chromatography (9) . Is benzo [a] pyrene metabolized by all tissue lineages that develop in the early postimplantation mouse embryo, including those that give rise to the fetus and placenta, or only by certain embryonic tissues, as suggested by Filler and Lew (9) ?
Here, we confirm that benzo [a] pyrene is metabolically activated in genetically responsive mouse blastocysts, and we characterize the distribution of cytochrome P-450 activity in the embryonic and extraembryonic tissue lineages of early postimplantation-stage embryos. The embryonic half of the 71/2-day early postimplantation mouse egg cylinder already has several layers: primitive endoderm, mesoderm, and ectoderm. Embryonic ectoderm gives rise to the entire fetus (10) . The extraembryonic half of the egg cylinder consists of visceral yolk sac, allantois, chorion, and ectoplacental cone. The latter three fuse to form the chorioallantoic placenta at about 9 days of gestation (see ref. 10 for review).
To determine cytochrome P-450 metabolic capacity, we used the SCE assay to detect reactive intermediates of benzo[a]pyrene. SCE is a sensitive, albeit indirect, indicator of DNA lesions that produce exchanges between sister chromatids during DNA synthesis (11, 12) . These can be detected by incorporating the thymidine analogue 5-bromodeoxyuridine (BrdUrd) for two cycles of DNA synthesis, followed by fluorescence-plus-Giemsa staining of fixed chromosomes (13) . The SCE assay is particularly suitable for early mammalian embryos, which contain limited numbers of cells (8 tained by dissection before culture by using the trypsin/pancreatin procedure (15) . These tissue fractions were treated in modified Eagle's medium in organ culture dishes. In both approaches, BrdUrd was added to a final concentration of 0.15 mM. This higher concentration of BrdUrd was necessary to detect SCE in embryonic and extraembryonic ectoderm, as a result of the lower levels of BrdUrd incorporation in these tissues (unpublished observations). After 21.5-hr culture, Colcemid (0.2 AM) was added and incubation was continued for 2.5 hr before chromosome fixation.
Chromosome Preparation and Staining. Each group of preimplantation embryos was exposed for up to 30 min to 0.5% (hypotonic) sodium citrate,, then transferred into fixative [methanol/glacial acetic acid, 1:1 (vol/vol)], and onto a slide as previously described (16) . Chromosome preparations were stained by modification 2 of the fluorescenceplus-Giemsa technique (8), using long-wavelength ultraviolet (black) light.
Intact postimplantation embryos were exposed after benzo[a]pyrene treatment to freshly prepared 0.075 M (hypotonic) KCl for 5-10 min, then dissected into embryonic and extraembryonic regions with glass needles. Tissue fractions dissected before treatment were exposed to hypotonic KCI in the same way. Two to four whole embryos or their isolated tissues were pooled for each point, then fixed for 10 min in methanol/acetic acid (3:1, vol/vol). Chromosomes were spread (8) and stained as described for preimplantation embryos.
SCEs were counted in well-spread metaphases to determine the number of exchanges per chromosome and per cell (normalized to a diploid value of 40 chromosomes). The 40 . Differences were evaluated on the basis of a Z statistic for differences between Poisson populations, using the standard normal distribution (17) .
RESULTS
Our studies confirmed the conclusion of Filler and Lew (9) that the capacity to metabolize benzo [a] (18) .
When whole embryos were exposed to 0.25-2.5 ,M benzo[a]pyrene at gestational day 71/2, benzo[a]pyrene induced SCE in both the extraembryonic region and the embryonic region of C3H/AnfCum embryos ( Table 2) . There was a 6-to 7-fold increase in the extraembryonic region, and a 3-to 4-fold increase in SCE in the embryonic region. When individual tissues were exposed, extraembryonic endoderm had more SCE than extraembryonic ectoderm, but the result was based on very few cells and the relative increase was similar in the two tissues ( tSignificantly greater than control (P < 0.01).
Proc. NaM Acad Sci. USA 82 (1985) (11, 12) . At the morula-blastocyst transition in mice, many enzyme activities increase-e.g., those involved in transport systems and macromolecular synthesis (reviewed in ref. 19 ). Thus, cytochrome P-450 activity appears during increased overall metabolic activity before implantation. After implantation, there is a relatively uniform rate of energy metabolism in mouse embryos (20) .
Precisely when do mouse embryos acquire their ability to metabolize benzo[a]pyrene? The SCE assay detects DNA lesions incurred before or during the first and second S phases after addition of BrdUrd. Morulae would complete their second S phase 2-3 hr before the end of culture (i.e, the length of G2) (21) (23, 24) .
Our major conclusion from analysis of postimplantation embryos is that, in genetically responsive mice, both the tissue lineages giving rise to the fetus and those giving rise to the placenta have acquired the ability to metabolize benzo [a] pyrene. The only embryonic tissue lineage that was not examined in isolation was mesoderm; because levels of SCE in intact tissues containing mesoderm equaled those in tissues dissected free of mesoderm, it is likely that mesoderm also has cytochrome P-450 metabolic activity. Thus, the cytochrome P-450 metabolic capacities of all fetal and placental tissues could be decisive factors in the developmental risk of exposure to polycyclic aromatic hydrocarbons during early gestation.
Because dissected endoderm had higher SCE values than dissected ectoderm, even when both tissues were exposed equally to benzo[a]pyrene, endoderm may have higher lev- n SCEs/cell n SCEs/cell n SCEs/cell n SCEs/cell n SCEs/cell n SCEs/cell n SCEs/cell 0 373 3.0 ± 0.6 369 2.6 ± 0.5 242 2.8 ± 0.7 365 6.1 ± 0.8 309 0.9 ± 0.3 553 6.5 ± 0.7 396 7.1 ± 0. Table 1 ; n = number of chromosomes scored.
*Significantly greater than control (P < 0.001).
tSignificantly greater than control (P < 0.01).
Developmental Biology: Pedersen et aL els of cytochrome P-450 activity. Furthermore, endoderm was probably responsible for the high SCE values observed in the intact 71/2-day regions studied here and in the whole embryos studied previously (8) . This is interesting in view of the similarity of yolk sac biochemical differentiation with the fetal liver (e.g., a-fetoprotein synthesis) (25) . Mouse embryonal carcinoma cells, which are believed to be analogous to those of early postimplantation embryos (26) , are also capable of metabolizing benzo[a]pyrene to mutagenic forms (27, 28) .
The nature and disposition of benzo[a]pyrene metabolites within the conceptus might depend on the metabolic activity of the placental and fetal tissues. Placental detoxication (e.g., polyoxygenation, conjugation) alone could conceivably provide some protection from reactive products of benzo[a]pyrene metabolism, but it cannot confer protection from parent compound that reaches the embryo proper, since embryonic tissues are also metabolically competent. In the intact maternal-fetal-placental unit, other factors besides metabolic activation could also influence the embryotoxicity of benzo[a]pyrene. As demonstrated by Schreck and Latt (29) , SCE frequency did not correlate with Ah genotype in adult tissues of mice treated with benzo[a]pyrene in vivo. They observed a similar disparity between activities of phenobarbital-induced drug-metabolizing enzymes (not associated with the Ah locus) and SCE frequencies in mice treated with cyclophosphamide (30) . Thus, it appears that the induced SCE frequency in mice in vivo is influenced by genetic differences not only in drug activation but also in drug detoxication or absorption. For example, oral administration of benzo[a]pyrene to nonresponsive pregnant mice leads to greater embryotoxicity in nonresponsive embryos than in responsive embryos, which is the opposite of the results obtained after intraperitoneal administration (7, (31) (32) (33) .
The capacity for DNA repair also varies among certain strains of mice, as indicated by the differences in the frequency of SCE induced by residual lesions, when eggs of these strains were fertilized by ultraviolet-irradiated sperm (34) . However, consistently high levels of benzo[a]pyreneinduced SCE in embryos of strains high in repair capacity (C57BL/6) or low in repair capacity (BALB/c) (8) (35, 36) . This concept is based primarily on the extreme toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which binds specifically to the receptor product of the Ah locus (3, 37, 38) and leads to cleft palate and other defects in Ah-responsive mice (39, 40) . Even though cytochrome P-450 induction is a major consequence of TCDD exposure in Ah-responsive mice, enzymes controlled by the Ah receptor are not necessarily responsible for the effects of TCDD; rather, persistent occupation of the Ah receptor itself could interfere with essential cellular regulatory events within the developing embryo or fetus, as postulated by Poland et al. (35) . One implication of this idea is that there may be an endogenous ligand for the Ah receptor. The observation of benzo [a] pyrene metabolism in all tissue lineages examined at 71/2 to 81/2 days of gestation, and in blastocysts (refs. 10, 41, and this study), implies that the Ah locus is expressed throughout the earliest morphogenetic events in mammalian development.
If the sole function of the cytochrome P-450 expression in the early embryo were environmental surveillance, one might expect other drug-metabolizing systems to be similarly active. However, there is no detectable activity of the phenobarbital-induced cytochrome P-450 system (not associated with the Ah locus) in 9-day rat embryos (42) or in cultured rat yolk sac cells (43) . Furthermore, predominance of quinone formation in mouse embryos treated with benzo[a]pyrene at 4 days of gestation (9) or at 10 days of gestation (33) suggests that detoxication enzymes are relatively inactive at early stages of development. Metabolism of benzo[a]pyrene by cytochrome P-450-mediated oxidation is thus the only system known to be active very early in gestation. Similar cytochrome P-450 metabolic activities are also detectable at very early stages (day 3 of incubation) of chicken embryo development (44) and in fish embryos at later stages (45) . This early expression may be evidence for a role of the Ah locus in normal mammalian development other than metabolism of xenobiotics. However, further work is needed to identify the cytochrome P-450 form(s) active in early vertebrate development and to characterize their normal function.
